Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Cells Activity”

575 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 575 results

Early research (Phase 1)Not Yet RecruitingNCT07254793
What this trial is testing

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

Who this might be right for
Acute Lymphoid LeukemiaAcute Myeloid LeukemiaAcute Undifferentiated Leukemia (AUL)+3 more
University of Arizona 94
Not applicableNot Yet RecruitingNCT06839014
What this trial is testing

Exercise Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Squamous Cell Carcinoma HNSCC
Our Lady of the Lake Hospital 40
Early research (Phase 1)Ended earlyNCT04045028
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaB-Cell Lymphoma
Genentech, Inc. 41
Not applicableActive Not RecruitingNCT07026799
What this trial is testing

Feasibility, Safety and Effectivity of an Exercise Intervention for Newly Diagnosed Multiple Myeloma Patients During Induction Therapy

Who this might be right for
Multiple Myeloma Bone Lesions
University Hospital Heidelberg 50
Not applicableStudy completedNCT06171945
What this trial is testing

Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivors

Who this might be right for
CancerPhysical ActivityCancer Survivorship+2 more
UNC Lineberger Comprehensive Cancer Center 63
Testing effectiveness (Phase 2)Ended earlyNCT04767698
What this trial is testing

Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Johns Hopkins University 4
Post-approval studies (Phase 4)Study completedNCT03853746
What this trial is testing

Short-term B-cell Depletion in Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Johns Hopkins University 10
Testing effectiveness (Phase 2)Study completedNCT01814488
What this trial is testing

A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia

Who this might be right for
Acute Leukemia
Gruppo Italiano Trapianto di Midollo Osseo 101
Not applicableUnknownNCT02926300
What this trial is testing

Long-term Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD)

Who this might be right for
Crohn's Disease
Kang Stem Biotech Co., Ltd. 24
Early research (Phase 1)Study completedNCT05775406
What this trial is testing

Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors

Who this might be right for
Myeloid MalignanciesAcute Lymphocytic LeukemiaLymphomas+1 more
Kymera Therapeutics, Inc. 52
Testing effectiveness (Phase 2)Looking for participantsNCT05963347
What this trial is testing

Go-CHOP as the Frontline Therapy for PTCL

Who this might be right for
Peripheral T Cell Lymphoma
Henan Cancer Hospital 45
Early research (Phase 1)Looking for participantsNCT06375044
What this trial is testing

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Jiangsu Simcere Pharmaceutical Co., Ltd. 130
Testing effectiveness (Phase 2)WithdrawnNCT03739606
What this trial is testing

Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center
Not applicableUnknownNCT04096222
What this trial is testing

Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients

Who this might be right for
Pemphigus VulgarisBullous DermatosesAutoimmune Diseases
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 42
Testing effectiveness (Phase 2)Ended earlyNCT01999192
What this trial is testing

Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Biotest 321
Early research (Phase 1)Active Not RecruitingNCT00710892
What this trial is testing

CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene

Who this might be right for
Acute Lymphoblastic LeukemiaNon-Hodgkin's LymphomaMyelodysplastic Syndrome+1 more
Baylor College of Medicine 10
Not applicableStudy completedNCT00089739
What this trial is testing

Immune Indicators of Uveitis

Who this might be right for
GITRGITR LigandUveitis+2 more
National Eye Institute (NEI) 100
Early research (Phase 1)Ended earlyNCT00963495
What this trial is testing

Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+4 more
University Health Network, Toronto 11
Early research (Phase 1)Looking for participantsNCT04970901
What this trial is testing

Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)

Who this might be right for
B-Cell Non-Hodgkin LymphomaRelapsed B-Cell Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin Lymphoma
ADC Therapeutics S.A. 200
Testing effectiveness (Phase 2)Looking for participantsNCT06121297
What this trial is testing

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Cabaletta Bio 28
Load More Results